{"id":2426,"date":"2018-03-06T19:48:00","date_gmt":"2018-03-06T19:48:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2426"},"modified":"2025-01-15T03:15:56","modified_gmt":"2025-01-15T03:15:56","slug":"hepatitis-c-the-beginning-of-the-end-key-elements-for-successful-european-and-national-strategies-to-eliminate-hcv-in-europe","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/hepatitis-c-the-beginning-of-the-end-key-elements-for-successful-european-and-national-strategies-to-eliminate-hcv-in-europe\/","title":{"rendered":"H\u00e9patite C: le d\u00e9but de la fin - \u00e9l\u00e9ments cl\u00e9s pour le succ\u00e8s des strat\u00e9gies europ\u00e9ennes et nationales visant \u00e0 \u00e9liminer le VHC en Europe"},"content":{"rendered":"

R\u00e9sum\u00e9<\/h2>\n\n\n\n

L'infection par le virus de l'h\u00e9patite C (VHC) est un probl\u00e8me de sant\u00e9 publique majeur dans l'Union europ\u00e9enne (UE). On estime que 5,6 millions d'Europ\u00e9ens sont chroniquement infect\u00e9s avec une large gamme de variations de pr\u00e9valence dans les pays de l'Union europ\u00e9enne. Bien que le VHC continue de se propager en tant que \u00abpand\u00e9mie silencieuse\u00bb, son \u00e9limination est rendue possible gr\u00e2ce \u00e0 la disponibilit\u00e9 des nouveaux m\u00e9dicaments antiviraux et \u00e0 la mise en \u0153uvre de pratiques de pr\u00e9vention. Le 17 f\u00e9vrier 2016, l'Association des politiques publiques de l'h\u00e9patite B et C a organis\u00e9 le premier sommet politique de l'UE sur le VHC \u00e0 Bruxelles. Ce sommet a \u00e9t\u00e9 un \u00e9v\u00e9nement historique car il s'agissait de la premi\u00e8re conf\u00e9rence de haut niveau consacr\u00e9e \u00e0 l'\u00e9limination du VHC au niveau de l'Union europ\u00e9enne. La r\u00e9union a rassembl\u00e9 les principales parties prenantes dans le domaine du VHC: des cliniciens, des groupes de d\u00e9fense des patients, des repr\u00e9sentants d'institutions cl\u00e9s et d'organismes r\u00e9gionaux de toute l'Union europ\u00e9enne; il a servi de plate-forme pour l'une des campagnes d'\u00e9limination des maladies les plus importantes en Europe et a abouti \u00e0 la pr\u00e9sentation du Manifeste pour l'\u00e9limination du VHC, appelant \u00e0 l'\u00e9limination du VHC en Europe d'ici 2030. Le lancement du Manifeste pour l'\u00e9limination constitue un point de d\u00e9part pour l'action afin de faire du VHC et de son \u00e9limination en Europe une priorit\u00e9 de sant\u00e9 publique explicite, de veiller \u00e0 ce que les patients, les groupes de la soci\u00e9t\u00e9 civile et les autres parties prenantes concern\u00e9es soient directement impliqu\u00e9s dans l'\u00e9laboration et la mise en \u0153uvre de strat\u00e9gies d'\u00e9limination du VHC, d'accorder une attention particuli\u00e8re aux liens entre l'h\u00e9patite C et la marginalisation sociale et d\u2019introduire une semaine europ\u00e9enne de sensibilisation \u00e0 l\u2019h\u00e9patite.<\/p>\n\n

\n
Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Summary Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely \u201csilent pandemic,\u201d its elimination is made possible through the availability […]<\/p>\n","protected":false},"author":24,"featured_media":3193,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[31,10],"publication-author":[892,885,890,886,502,510,671,893,889,798,884,499,873,888,894,898,494,887,899,895,896,891,897],"class_list":["post-2426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-elimination","tag-hcv","publication-author-baptista-leite-r","publication-author-baskozos-i","publication-author-chhatwal-j","publication-author-cholongitas-e","publication-author-colombo-m","publication-author-cortez-pinto-h","publication-author-craxi-a","publication-author-goldberg-d","publication-author-gore-c","publication-author-hatzakis-a","publication-author-kautz-a","publication-author-lazarus-jv","publication-author-manns-mp","publication-author-mendao-l","publication-author-papatheodoridis-gv","publication-author-peck-radosavljevic-m","publication-author-razavi-h","publication-author-schatz-e","publication-author-tozun-n","publication-author-van-damme-p","publication-author-wedemeyer-h","publication-author-yazdanpanah-y","publication-author-zuure-f"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=2426"}],"version-history":[{"count":7,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2426\/revisions"}],"predecessor-version":[{"id":7541,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2426\/revisions\/7541"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3193"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=2426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=2426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=2426"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=2426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}